<unk>  should not be used in people with hepatitis B infection or a history of severe reaction to this drug. If someone has an infection or infectious disease, treatment should be delayed until the infection is resolved. It has not been tested in pregnant women, but based on animal studies does not appear to be safe for pregnant women to take; it is excreted in breast milk, and effects on infants are unknown.
Ocrelizumab
Risankizumab
Ibalizumab
Theralizumab
Brolucizumab
Atezolizumab
Inebilizumab
Etaracizumab